ITGB2 and neoplasm: Notably, co-culture of IL-33 EO with tumor cells in the presence of anti-CD18 blocking mAb significantly inhibited the formation of eosinophil-tumor cell conjugates (Figure 7E, Figure S10) and significantly reduced tumor cell killing (Figure 7F).